Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Neuroimaging in psychiatric disorders.

Literature DB >> 21274689

Neuroimaging in psychiatric disorders.

Abstract

In psychiatry, neuroimaging facilitates the diagnosis of psychiatric disorders and the development of new medications. It is used to detect structural lesions causing psychosis and to differentiate depression from neurodegenerative disorders or brain tumors. Functional neuroimaging, mostly in the form of molecular neuroimaging with positron emission tomography or single photon emission tomography, facilitates the identification of therapeutic targets, the determination of the dose of a new drug needed to occupy its target in the brain, and the selection of patients for clinical trials.

Entities: Chemical Disease Gene Species

Mesh：

Year: 2011 PMID： 21274689 PMCID： PMC3052989 DOI： 10.1007/s13311-010-0006-0

Source DB: PubMed Journal: Neurotherapeutics ISSN： 1878-7479 Impact factor: 7.620

54 in total

1. SPECT perfusion imaging in the diagnosis of Alzheimer's disease: a clinical-pathologic study.

Authors: W Jagust; R Thisted; M D Devous; R Van Heertum; H Mayberg; K Jobst; A D Smith; N Borys
Journal: Neurology Date: 2001-04-10 Impact factor: 9.910

Review 2. Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies.

Authors: L J Lesko; A J Atkinson
Journal: Annu Rev Pharmacol Toxicol Date: 2001 Impact factor: 13.820

3. Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia.

Authors: S Kapur; R Zipursky; C Jones; G Remington; S Houle
Journal: Am J Psychiatry Date: 2000-04 Impact factor: 18.112

4. Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome.

Authors: D H Silverman; G W Small; C Y Chang; C S Lu; M A Kung De Aburto; W Chen; J Czernin; S I Rapoport; P Pietrini; G E Alexander; M B Schapiro; W J Jagust; J M Hoffman; K A Welsh-Bohmer; A Alavi; C M Clark; E Salmon; M J de Leon; R Mielke; J L Cummings; A P Kowell; S S Gambhir; C K Hoh; M E Phelps
Journal: JAMA Date: 2001-11-07 Impact factor: 56.272

5. Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia.

Authors: Andreas Meyer-Lindenberg; Robert S Miletich; Philip D Kohn; Giuseppe Esposito; Richard E Carson; Mario Quarantelli; Daniel R Weinberger; Karen Faith Berman
Journal: Nat Neurosci Date: 2002-03 Impact factor: 24.884

6. Subjective memory complaints: objective neural markers in patients with Alzheimer's disease and major depressive disorder.

Authors: Georg Grön; Daniel Bittner; Bernd Schmitz; Arthur P Wunderlich; Matthias W Riepe
Journal: Ann Neurol Date: 2002-04 Impact factor: 10.422

7. Impact of dopamine transporter SPECT using 123I-Ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian syndromes.

Authors: Ana M Catafau; Eduardo Tolosa
Journal: Mov Disord Date: 2004-10 Impact factor: 10.338

8. Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride.

Authors: Fuji Yokoi; Gerhard Gründer; Kathleen Biziere; Massoud Stephane; Ahmet S Dogan; Robert F Dannals; Hayden Ravert; Ajit Suri; Steven Bramer; Dean F Wong
Journal: Neuropsychopharmacology Date: 2002-08 Impact factor: 7.853

9. High levels of serotonin transporter occupancy with low-dose clomipramine in comparative occupancy study with fluvoxamine using positron emission tomography.

Authors: Tetsuya Suhara; Akihiro Takano; Yasuhiko Sudo; Tetsuya Ichimiya; Makoto Inoue; Fumihiko Yasuno; Yoko Ikoma; Yoshiro Okubo
Journal: Arch Gen Psychiatry Date: 2003-04

10. Prevalence of psychosis in epilepsy as a function of the laterality of the epileptogenic lesion.

Authors: I Sherwin; P Peron-Magnan; J Bancaud; A Bonis; J Talairach
Journal: Arch Neurol Date: 1982-10

16 in total

Review 1. Unfolding the Role of BDNF as a Biomarker for Treatment of Depression.

Authors: Tarapati Rana; Tapan Behl; Aayush Sehgal; Pranay Srivastava; Simona Bungau
Journal: J Mol Neurosci Date: 2020-11-23 Impact factor: 3.444

2. Multimodal Abnormalities of Brain Structure and Function in Major Depressive Disorder: A Meta-Analysis of Neuroimaging Studies.

Authors: Jodie P Gray; Veronika I Müller; Simon B Eickhoff; Peter T Fox
Journal: Am J Psychiatry Date: 2020-02-26 Impact factor: 18.112

10. A retrospective chart review of clinical characteristics and magnetic resonance imaging findings of patients from a psychiatric facility in KwaZulu-Natal province, South Africa.

Authors: Vidette M Juby; Saeeda Paruk
Journal: S Afr J Psychiatr Date: 2019-11-27 Impact factor: 1.550

Neuroimaging in psychiatric disorders.

1. SPECT perfusion imaging in the diagnosis of Alzheimer's disease: a clinical-pathologic study.

Review 2. Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies.

3. Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia.

4. Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome.

5. Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia.

6. Subjective memory complaints: objective neural markers in patients with Alzheimer's disease and major depressive disorder.

7. Impact of dopamine transporter SPECT using 123I-Ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian syndromes.

8. Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride.

9. High levels of serotonin transporter occupancy with low-dose clomipramine in comparative occupancy study with fluvoxamine using positron emission tomography.

10. Prevalence of psychosis in epilepsy as a function of the laterality of the epileptogenic lesion.

Review 1. Unfolding the Role of BDNF as a Biomarker for Treatment of Depression.

2. Multimodal Abnormalities of Brain Structure and Function in Major Depressive Disorder: A Meta-Analysis of Neuroimaging Studies.

Review 3. Towards automated detection of depression from brain structural magnetic resonance images.

4. Clinical use of neuro-imaging in psychiatric patients at the Charlotte Maxeke Johannesburg Academic Hospital.

5. Metabolic and functional connectivity changes in mal de debarquement syndrome.

Review 6. Brain-Derived Neurotrophic Factor, Depression, and Physical Activity: Making the Neuroplastic Connection.

Review 7. Physical Activity Modulates Common Neuroplasticity Substrates in Major Depressive and Bipolar Disorder.

8. Welcome biological breakthroughs, supply psychosocial insights.

9. Extracellular Vesicles in Psychiatry Research in the Context of RDoC Criteria.

10. A retrospective chart review of clinical characteristics and magnetic resonance imaging findings of patients from a psychiatric facility in KwaZulu-Natal province, South Africa.